Skip to content
HowShorted

KalVista Pharmaceuticals, Inc. short interest in 2026

In 2026, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 39.25% of shares outstanding on 15 Jan 2026 to 13.36% on 29 May 2026, a change of -25.89 percentage points. The year's high was 39.75% on 31 Mar 2026 and its low 13.36% on 29 May 2026, averaging 33.94% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.75 days on 27 Feb 2026. Full history: KalVista Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for KalVista Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
39.25% (15 Jan 2026)
End of year
13.36% (29 May 2026)
Change
-25.89 pp
High
39.75% (31 Mar 2026)
Low
13.36% (29 May 2026)
Average
33.94%
Highest days to cover
38.75 (27 Feb 2026)
SEC filings marked
3

Every report in 2026

KalVista Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202639.25%11.16results (8-K)
30 Jan 202639.71%25.44
13 Feb 202639.18%28.78
27 Feb 202638.16%38.75
13 Mar 202638.46%17.65
31 Mar 202639.75%15.92results (8-K)
15 Apr 202638.35%20.74
30 Apr 202629.60%1.83
15 May 202623.53%3.0710-Q filed
29 May 202613.36%1.97

See also: KalVista Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.